Cargando…
Immunomodulation exerted by galectins: a land of opportunity in rare cancers
Rare cancers represent only 5% of newly diagnosed malignancies. However, in some cases, they account for up to 50% of the deaths attributed to cancer in their corresponding organ. Part of the reason is that treatment options are generally quite limited, non-specific, and very often, only palliative....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10663293/ https://www.ncbi.nlm.nih.gov/pubmed/38022609 http://dx.doi.org/10.3389/fimmu.2023.1301025 |